Karyopharm Therapeutics
KPTI
#10901
Rank
HK$89.89 M
Marketcap
HK$3.96
Share price
-16.51%
Change (1 day)
-90.93%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: HK$89.89 Million

As of October 2026 Karyopharm Therapeutics has a market cap of HK$89.89 Million. This makes Karyopharm Therapeutics the world's 10901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$89.89 M-90.89%
2025HK$0.98 B43.72%
2024HK$0.68 B-11.24%
2023HK$0.77 B-74.27%
2022HK$3.00 B-20.6%
2021HK$3.78 B-57.11%
2020HK$8.83 B-9.5%
2019HK$9.75 B118.66%
2018HK$4.46 B26.13%
2017HK$3.53 B17.71%
2016HK$3.00 B-18.38%
2015HK$3.68 B-61.2%
2014HK$9.49 B80.53%
2013HK$5.25 B

End of Day market cap according to different sources

On Oct 12th, 2026 the market cap of Karyopharm Therapeutics was reported to be:

HK$89.89 Million
by Nasdaq info icon info icon
HK$89.89 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
HK$1.391 T 1,547,954.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.815 T 3,132,209.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$922.93 B 1,026,570.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$116.30 B 129,280.02%๐Ÿ‡บ๐Ÿ‡ธ USA